[go: up one dir, main page]

ZA200509379B - Memantine oral dosage forms - Google Patents

Memantine oral dosage forms

Info

Publication number
ZA200509379B
ZA200509379B ZA200509379A ZA200509379A ZA200509379B ZA 200509379 B ZA200509379 B ZA 200509379B ZA 200509379 A ZA200509379 A ZA 200509379A ZA 200509379 A ZA200509379 A ZA 200509379A ZA 200509379 B ZA200509379 B ZA 200509379B
Authority
ZA
South Africa
Prior art keywords
dosage forms
oral dosage
memantine oral
memantine
forms
Prior art date
Application number
ZA200509379A
Other languages
English (en)
Inventor
Bruce A Firestone
Janet K Cheetham
Teresa H Kuan
J Abraham M Espiritu
Zanden John J Vander
Kurjan Richard
Chang Chin-Ming
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of ZA200509379B publication Critical patent/ZA200509379B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200509379A 2003-06-16 2005-11-17 Memantine oral dosage forms ZA200509379B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47897903P 2003-06-16 2003-06-16

Publications (1)

Publication Number Publication Date
ZA200509379B true ZA200509379B (en) 2006-11-29

Family

ID=33539133

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200509379A ZA200509379B (en) 2003-06-16 2005-11-17 Memantine oral dosage forms

Country Status (16)

Country Link
US (2) US20040254251A1 (xx)
EP (1) EP1631273A1 (xx)
JP (1) JP2006527774A (xx)
KR (1) KR20060033727A (xx)
CN (1) CN1805737A (xx)
AU (1) AU2004249151A1 (xx)
BR (1) BRPI0411451A (xx)
CA (1) CA2529535A1 (xx)
IL (1) IL172233A0 (xx)
MX (1) MXPA05012810A (xx)
NO (1) NO20055880L (xx)
PL (1) PL378902A1 (xx)
RU (1) RU2006101225A (xx)
TW (1) TW200524639A (xx)
WO (1) WO2004112768A1 (xx)
ZA (1) ZA200509379B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7086532B2 (en) * 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
FR2855344A1 (fr) * 2003-05-22 2004-11-26 France Telecom Systeme de gestion de contexte pour un reseau comportant un ensemble heterogene de terminaux
JP5025468B2 (ja) * 2004-06-17 2012-09-12 メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン メマンチン又はネラメキサンの直接圧縮によって製造された、飲用に適した即効型錠剤
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
WO2006058059A2 (en) * 2004-11-23 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
MX2007012374A (es) 2005-04-06 2008-02-22 Adamas Pharmaceuticals Inc Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
JP5597343B2 (ja) * 2005-04-28 2014-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有する組成物
AU2007215005A1 (en) * 2006-02-10 2007-08-23 Janssen Pharmaceutica N.V. Novel tricyclic dihydropyrazines as potassium channel openers
US20090176736A1 (en) * 2006-04-20 2009-07-09 Katsumi Dohura Pharmaceutical composition for conformational diseases
WO2008005036A1 (en) * 2006-07-05 2008-01-10 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions of memantine
EP1908748A1 (en) * 2006-10-05 2008-04-09 Krka Process for the preparation of memantine and its hydrochloric acid salt form
KR20090087009A (ko) * 2006-10-27 2009-08-14 메디베이션 뉴롤로지 인코퍼레이티드 아이.에이. 다임본 및 도레페질을 사용하여 알츠하이머 병을 치료하기 위한 조합 요법
US20080182908A1 (en) * 2007-01-25 2008-07-31 Vinita Umashankar Vyas Pharmaceutical compositions comprising memantine
US20100292341A1 (en) * 2007-06-29 2010-11-18 Orchid Chemicals & Pharmaceuticals Limited Quick dissolve compositions of memantine hydrochloride
WO2009084017A2 (en) 2007-10-10 2009-07-09 Rubicon Research Private Limited Taste-masked orally disintegrating tablets of memantine hydrochloride
WO2009091932A2 (en) * 2008-01-18 2009-07-23 Adamas Pharmaceuticals, Inc. Treatment of mild dementia of the alzheimer's disease type
US20090247644A1 (en) * 2008-03-28 2009-10-01 Forest Laboratories Holdings Limited Memantine formulations
JP5885668B2 (ja) 2009-12-02 2016-03-15 アダマス ファーマシューティカルズ， インコーポレイテッド アマンタジン組成物および使用方法
BR112014026292B1 (pt) * 2012-04-24 2022-09-27 Daiichi Sankyo Company, Limited Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
KR20190076711A (ko) 2017-12-22 2019-07-02 한미약품 주식회사 메만틴을 포함하는 속방성 및 서방성을 동시에 가지는 경질캡슐 제제 및 그 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2856393C2 (de) * 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6849271B2 (en) * 2001-04-27 2005-02-01 Verion, Inc. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods

Also Published As

Publication number Publication date
MXPA05012810A (es) 2006-02-13
EP1631273A1 (en) 2006-03-08
RU2006101225A (ru) 2006-06-10
JP2006527774A (ja) 2006-12-07
CN1805737A (zh) 2006-07-19
AU2004249151A1 (en) 2004-12-29
BRPI0411451A (pt) 2006-07-18
KR20060033727A (ko) 2006-04-19
NO20055880L (no) 2005-12-28
IL172233A0 (en) 2006-04-10
CA2529535A1 (en) 2004-12-29
WO2004112768A1 (en) 2004-12-29
TW200524639A (en) 2005-08-01
PL378902A1 (pl) 2006-05-29
US20040254251A1 (en) 2004-12-16
US20060251717A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
ZA200509379B (en) Memantine oral dosage forms
GB0322284D0 (en) Medicament dispenser
GB0217225D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0324886D0 (en) Medicinal compounds
EP1553925A4 (en) ORAL DOSAGE FORM WITH MODIFIED RELEASE
GB0303396D0 (en) Medicinal compounds
GB0302671D0 (en) Pharmaceutical formulations
AU2003238670A8 (en) Fast disintegrating oral dosage forms
PL377495A1 (pl) Stały lek do stosowania doustnego
IL174342A0 (en) Chronotherapeutic dosage forms
GB0209668D0 (en) Oral devices
IL172824A0 (en) Pharmaceutical formulations
GB0302672D0 (en) Pharmaceutical formulations
GB0328490D0 (en) Medicinal compounds
GB0325383D0 (en) Oral formulations
GB0206505D0 (en) Pharmaceutical combination
GB0316341D0 (en) Pharmaceutical formulations
IL174009A0 (en) Melt-formulated, multi-particulate oral dosage form
ZA200600560B (en) Combined doses
PL373409A1 (en) Pharmaceutical combination
HK1089381A (en) Memantine oral dosage forms
GB0315019D0 (en) Dosage form
GB0316335D0 (en) Pharmaceutical formulations